인제대학교 상계백병원은 인제대학교 부속 종합병원이다. 서울특별시 노원구 동일로 1342에 위치하고 있다.

During the past decade, Inje University Sanggye Paik Hospital conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 7 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inje University Sanggye Paik Hospital" #1 sponsor was "Inje University" with 7 trials, followed by "Asan Medical Center" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Allergan" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inje University Sanggye Paik Hospital" #1 collaborator was "Hanyang University" with 3 trials as a collaborator, "Inje University" with 3 trials as a collaborator, "Korean Cancer Study Group" with 3 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 2 trials as a collaborator and "Chung-Ang University Hosptial, Chung-Ang University College of Medicine" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Inje University Sanggye Paik Hospital" are "Diabetes Mellitus" (3 trials), "Diabetes Mellitus, Type 2" (3 trials), "Gastroparesis" (3 trials), "Alzheimer's Disease" (2 trials) and "Bladder Cancer" (2 trials). Many other conditions were trialed in "Inje University Sanggye Paik Hospital" in a lesser frequency.

Most popular intervention types in "Inje University Sanggye Paik Hospital" are "Drug" (40 trials), "Device" (3 trials), "Other" (3 trials), "Procedure" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Aspirin" (2 trials), "CKD-501 0.5mg" (2 trials), "Dexamethasone" (2 trials) and "Relamorelin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Inje University Sanggye Paik Hospital" are 51 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Inje University Sanggye Paik Hospital". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Inje University Sanggye Paik Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Inje University Sanggye Paik Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 8 trials that are defined as “Not Applicable".